Always consult your vet before starting a cardiac supplement programme
Semaglutide, taken weekly, offers greater weight loss and blood-sugar improvement but can trigger stronger GI symptoms during dose escalation
Ensure adequate intake (500-1000 mg daily) during the healing period
In 2023, the FDA approved tirzepatide for obesity, which, according to Gratzl and colleagues, contributed to an increase in prescribing trends of GLP-1 medications
Solution: Drink water or sip herbal tea first
In SUSTAIN 3, SUSTAIN 7 and SUSTAIN 10, the GLP-1RAs semaglutide reduced HbA1c by up to 1.8%, achieved the glycemic control target of HbA1c in 80% of the intervention group, and reduced BW by up to 6.5 kg, outcomes which were superior to liraglutide, exenatide and dulaglutide [28-30]